| Financial Year |
March 31 2023 |
| Monetary Funds |
775,101,401.08 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
8,310,900.00 |
| Accounts Receivable |
899,014,194.89 |
| Advances to Suppliers |
61,679,406.86 |
| Other Receivables |
17,772,943.93 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
142,400,911.74 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
102,003,582.07 |
| Other Current Assets |
92,788,670.88 |
| Total Current Assets |
2,794,119,584.93 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
755,647,140.82 |
| Long-term Equity Investment |
979,949,163.27 |
| Investment Properties |
-- |
| Fixed Assetes |
2,244,045,233.35 |
| Under-construction Projects |
514,253,302.73 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
482,199,901.81 |
| R&D expenses |
-- |
| Goodwill |
151,666,449.40 |
| Long-Term Deferred and Prepaid Expenses |
96,369,013.08 |
| Deferred Income Tax Assets |
114,119,742.15 |
| Other Non-Current Assets |
12,908,078.22 |
| Sub-Total of Non-Current Assets |
5,459,035,215.97 |
| Total Assets |
8,253,154,800.90 |
| Short-Term Loans |
1,501,739,594.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
388,691,889.25 |
| Accounts Payable |
897,619,224.66 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,576,379.85 |
| Taxes Payable |
29,818,572.12 |
| Interest Payable |
-- |
| Dividend Payable |
531,522.61 |
| Other payables |
279,375,313.68 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
280,100,513.81 |
| Other Current Liabilities |
77,666,768.31 |
| Sub-Total of Current Liabilities |
3,529,298,918.21 |
| Long-term Loans |
1,038,564,927.86 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
320,560,737.24 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
30,632,891.79 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,073,814,343.51 |
| Total Liabilities |
5,603,113,261.72 |
| Paid-In Capital(Or Share Stock) |
352,658,600.00 |
| Capital Surplus |
1,090,265,046.41 |
| Surplus Reserve |
65,967,506.12 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
608,098,944.39 |
| Minority Stockholder's Interest |
533,051,442.26 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,116,990,096.92 |
| Owner's Equity（Stockholder's Equity） |
2,650,041,539.18 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,253,154,800.90 |
